Research References
Four molecule families have peer-reviewed clinical evidence supporting their use in microinfusion-style delivery: copper tripeptide GHK-Cu (collagen synthesis, gene-expression modulation), recombinant epidermal growth factor or sh-Oligopeptide-1 (keratinocyte proliferation, dermal restructuring), polydeoxyribonucleotide PDRN (adenosine A2A receptor activation, fibroblast stimulation, anti-melanogenesis), and a multi-molecular-weight hyaluronic acid system (50 kDa to 2000 kDa fractions, each with different penetration depth and biological role)
No health claims are made unless supported by multiple peer-reviewed studies
Epitalons potential role in this area has made it a point of interest among researchers and clinicians focused on aging, cellular resilience, and long-term health
PER1 has been suggested to influence cancer progression once cancer has been established
The peptide blocks NF-kB activation, a master switch for inflammatory gene expression